| Literature DB >> 33884272 |
Eon H Campbell1, Melanie Poudevigne2, Shelly McFarlane3, Lowell Dilworth4, Rachael Irving1.
Abstract
Although sleep disturbance is a common complaint in overtrained athletes, the role of sleep in the overtraining process is not clear. This study aimed (i) to compare sleep efficiency/quantity at the start of a competition phase in elite adolescent sprinters who adapted to prior training with that in those who maladapt and (ii) to examine the influence of prior training, fatigue, and sleep on performance through a moderated mediation model. Fatigue (via Profile of Mood State) and internal training load (via session rating of perceived exertion and duration of training as volume) were measured in 20 sprinters (mean age: 15.9 ± 1.7 years) across 4 mesocycles (baseline (T1); preparatory (T2); precompetitive (T3); and competitive (T4) phases), over 26 weeks. Performances were assessed during the competitive period (T3, T4), while sleep was monitored (via actigraphy) for a week during T4. It was inferred that sprinters who had increasingly greater fatigue and concomitant decrements in performance (35%) were maladapted to training and the remaining sprinters who improved fatigue and performance (65%) were adapted to training. Sleep efficiency (91 ± 3% vs. 82 ± 3%, p < 0.001) and quantity (425 ± 33 min vs. 394 ± 20 min, p < 0.001) at the start of T4 were significantly greater in sprinters who adapted. Moreover, higher prior training volume (mean of T1 to T3 training volume) was associated with lower sleep efficiency at the start of T4 (R 2 = 0.55, p < 0.001) which was associated with poorer performance (R 2 = 0.82, p < 0.001). Fatigue moderated the indirect effect of prior training volume on performance through its moderation of the effect of sleep efficiency on performance (R 2 = 0.89, p < 0.001). Impaired sleep as a result of greater prior training volume may be related to performance decrements through fatigue. Athletes should improve sleep during periods of higher training volume to reduce fatigue for better adaptation to training.Entities:
Year: 2021 PMID: 33884272 PMCID: PMC8041504 DOI: 10.1155/2021/6694547
Source DB: PubMed Journal: J Sports Med (Hindawi Publ Corp) ISSN: 2314-6176
Figure 1Schematic overview of the study design.
Descriptive characteristics of participants disaggregated based on athletes considered as adapted to and maladapted to training. Data are presented as mean ± SD.
| Variable | Overall ( | MG ( | AG ( |
|
|
|---|---|---|---|---|---|
| Age (year) | 15.9 ± 1.7 | 16.6 ± 1.9 | 15.5 ± 1.5 | 0.160 | 0.6 |
| Height (cm) | 173.0 ± 9.9 | 173.7 ± 10.4 | 172.6 ± 10.0 | 0.814 | 0.1 |
| Weight (kg) | 65.2 ± 12.7 | 67.1 ± 14.6 | 64.17 ± 12.17 | 0.634 | 0.2 |
| BMI (kg/m2) | 21.6 ± 2.3 | 22.0 ± 2.8 | 21.3 ± 2.1 | 0.548 | 0.3 |
| %BF | 13.0 ± 5.0 | 12.0 ± 3.9 | 13.6 ± 5.6 | 0.510 | 0.4 |
MG: maladapted group; AG: adapted group; d: Cohen' d effect size; %BF: percent body fat.
Mean ± SD and between-group effects as mean difference (95% confidence interval) for training parameters of participants according to training phases.
| Variables | T1 | T2 | T3 | T4 | Total between-group effects, MG-AG (95% CI) |
|---|---|---|---|---|---|
| Weekly no. TD | 5.3 ± 0.7 | 5.4 ± 0.6 | 5.1 ± 0.4 | 4.8 ± 0.7b | |
| MG | 5.1 ± 0.7 | 5.4 ± 0.5 | 5.0 ± 0.4 | 5.0 ± 0.0 | −0.03 (−0.3, 0.5)† |
| AG | 5.4 ± 0.7 | 5.4 ± 0.6 | 5.2 ± 0.4 | 4.5 ± 0.9 | |
|
| |||||
| Weekly TV | 12.2 ± 1.8 | 12.1 ± 1.8 | 10.5 ± 4.0 | 6.7 ± 1.9abc | |
| MG | 12.0 ± 1.9 | 12.5 ± 1.3 | 11.2 ± 3.9 | 8.5 ± 7.7‡ | 1.1 (−0.3, 2.4)† |
| AG | 12.3 ± 1.8 | 11.9 ± 2.0 | 10.1 ± 4.2 | 5.7 ± 1.1 | |
|
| |||||
| Internal TL | 3003.7 ± 764.9 | 3995.0 ± 1443.0a | 3928.8 ± 2332.6a | 2960.0 ± 1471.9 | |
| MG | 2739.1 ± 635.1 | 3997.1 ± 472.8 | 4165.0 ± 2869.7 | 3897.9 ± 1500.3‡ | 350.7 (−706.8, 1408.1)† |
| AG | 3146.8 ± 813.53 | 3993.8 ± 1784.7 | 3801.5 ± 2108.9 | 2455.0 ± 1231.0 | |
|
| |||||
| ACWR | 1.0 ± 0.3 | 1.0 ± 0.2 | 1.1 ± 0.3 | 0.9 ± 0.2 | |
| MG | 0.9 ± 0.2 | 1.0 ± 0.2 | 1.0 ± 0.3 | 1.0 ± 0.2 | 0.01 (−0.01, 0.03) |
| AG | 1.0 ± 0.3 | 1.1 ± 0.2 | 1.1 ± 0.3 | 0.8 ± 0.2 | |
†Significant time effect (repeated measure ANOVA, p < 0.05). ‡Significant group difference (independent t-test, p < 0.05). aSignificantly different from T1. bSignificantly different from T2. cSignificantly different from T3. No. TD: number of training days; TV: training volume in hours; TL: training load in arbitrary unit; ACWR: acute chronic work ratio; MG: maladapted group; AG: adapted group.
Mean ± SD and between-group effects as mean difference (95% confidence interval) for fatigue, total mood state, and other POMS scores corresponding to different phases of an athletic season.
| Variable | T1 | T2 | T3 | T4 | Total between-group effects, MG-AG (95% CI) |
|---|---|---|---|---|---|
| Fatigue | 6.0 ± 1.9 | 9.7 ± 5.7a | 8.2 ± 5.7a | 7.8 ± 5.0a | |
| MG | 6.9 ± 1.1 | 13.3 ± 5.7 | 14.4 ± 4.0‡ | 13.7 ± 2.9‡ | 6.4 (3.9, 8.9) |
| AG | 5.5 ± 2.1 | 7.8 ± 4.8 | 4.9 ± 3.0 | 4.5 ± 2.1 | |
|
| |||||
| Tension | 8.4 ± 4.7 | 8.0 ± 5.0 | 7.4 ± 4.8 | 7.2 ± 4.1 | |
| MG | 11.1 ± 3.6 | 10.6 ± 4.4 | 10.1 ± 4.7 | 9.9 ± 3.6‡ | 4.2 (0.7, 7.7) |
| AG | 6.9 ± 4.6 | 6.5 ± 4.9 | 5.9 ± 4.2 | 5.7 ± 3.7 | |
|
| |||||
| Anger | 6.6 ± 5.8 | 6.1 ± 5.7 | 6.0 ± 5.4 | 5.6 ± 4.4 | |
| MG | 7.1 ± 6.8 | 9.6 ± 5.4 | 7.4 ± 5.2 | 7.7 ± 4.9 | 3.1 (-1.4, 7.7) |
| AG | 6.0 ± 5.3 | 4.2 ± 5.0 | 5.2 ± 5.6 | 4.5 ± 3.9 | |
|
| |||||
| Vigor | 14.6 ± 3.4 | 13.7 ± 2.9 | 13.8 ± 3.5 | 13.5 ± 3.6 | |
| MG | 12.6 ± 2.7 | 13.0 ± 2.8 | 13.4 ± 2.5 | 12.6 ± 2.6 | -1.1 (-3.9, 1.8) |
| AG | 14.0 ± 2.9 | 14.0 ± 2.9 | 13.9 ± 4.0 | 13.9 ± 4.0 | |
|
| |||||
| Depression | 7.4 ± 4.3 | 6.6 ± 5.8 | 4.8 ± 4.7 | 5.1 ± 4.0 | |
| MG | 8.6 ± 4.9 | 10.0 ± 5.4‡ | 6.4 ± 5.3 | 7.7 ± 3.7‡ | 3.4 (-0.1, 7.0) |
| AG | 6.8 ± 4.1 | 4.7 ± 5.3 | 3.9 ± 4.3 | 3.7 ± 3.6 | |
|
| |||||
| Confusion | 5.7 ± 3.9 | 5.7 ± 4.4 | 5.5 ± 3.3 | 5.6 ± 3.1 | |
| MG | 7.0 ± 4.9 | 6.7 ± 5.4 | 6.7 ± 3.5 | 7.0 ± 3.3 | 2.0 (-1.1, 5.1) |
| AG | 4.9 ± 3.2 | 5.0 ± 3.8 | 4.9 ± 3.2 | 4.9 ± 2.8 | |
|
| |||||
| TMD | 19.4 ± 17.7 | 22.3 ± 24.2 | 18.0 ± 19.7 | 17.8 ± 18.1 | |
| MG | 27.8 ± 16.7 | 37.3 ± 21.7‡ | 31.7 ± 20.7‡ | 33.4 ± 17.6‡ | 20.3 (4.8, 35.9) |
| AG | 14.9 ± 17.0 | 14.2 ± 22.1 | 9.3 ± 12.0 | 9.3 ± 12.0 | |
†Significant time effect (repeated measure ANOVA, p < 0.05). ∗Significant group × time interaction (repeated measure ANOVA, p < 0.05). ‡Significant group difference (independent t-test, p < 0.05). aSignificantly different from T1. MG: maladapted group; AG: adapted group; TMD: total mood disturbance.
Mean ± SD of sleep actigraphy data during the competitive phase in two groups of athletes considered as adapted and maladapted to training.
| Variables | All ( | MG ( | AG ( |
|
|
|---|---|---|---|---|---|
| Bedtime (hh:mm) | 10 : 52 ± 0 : 55 | 11 : 13 ± 1 : 00 | 10 : 41 ± 0 : 52 | 0.226 | 0.4 |
| Get-up time (hh:mm) | 6 : 45 ± 1 : 06 | 7 : 17 ± 1 : 19 | 6 : 28 ± 0 : 54 | 0.119 | 0.7 |
| TIB (min) | 473.7 ± 37.4 | 484.6 ± 36.4 | 467.8 ± 38.0 | 0.349 | 0.5 |
| TST (min) | 414.5 ± 32.1 | 394.3 ± 20.4 | 425.3 ± 32.6 |
| 1.1 |
| SE% | 87.7 ± 5.5 | 81.5 ± 2.9 | 91.0 ± 3.4 |
| 3.0 |
| SOL (min) | 9.9 ± 7.0 | 14.8 ± 7.5 | 7.3 ± 5.3 |
| 1.2 |
| WASO (min) | 38.8 ± 15.9 | 49.4 ± 16.8 | 33.1 ± 12.7 |
| 1.1 |
| No. of awakenings | 23.6 ± 27.0 | 33.0 ± 32.6 | 18.5 ± 23.3 | 0.263 | 0.5 |
MG: maladapted group; AG: adapted group; d: Cohen' d effect size; TIB: time in bed; TST: total sleep time; SE%: sleep efficiency; SOL: sleep onset latency; WASO: wake after sleep onset.
Correlation calculated on pooled data for both adapted and maladapted athletes.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (1) Performance | — | — | — | — | — | — | — | — | — | — | — | — |
| (2) Internal TL | −0.27 | — | — | — | — | — | — | — | — | — | — | — |
| (3) Training volume | −0.79 | 0.14 | — | — | — | — | — | — | — | — | — | — |
| (4) Fatigue | −0.69 | 0.57 | 0.69 | — | — | — | — | — | — | — | — | — |
| (5) Tension | −0.16 | 0.47 | 0.21 | 0.62 | — | — | — | — | — | — | — | — |
| (6) Depression | −0.35 | 0.45 | 0.34 | 0.72 | 0.80 | — | — | — | — | — | — | — |
| (7) Absolute sIgA | 0.55∗ | −0.01 | −0.50 | −0.45 | −0.22 | 0.35 | — | — | — | — | — | — |
| (8) TMD | −0.44 | 0.61 | 0.44 | 0.84 | 0.85 | 0.91 | −0.33 | — | — | — | — | — |
| (9) TST | 0.60 | −0.25 | −0.70 | −0.83 | −0.51∗ | −0.56 | 0.53 | −0.69 | — | — | — | — |
| (10) SE% | 0.91 | −0.29 | −0.76 | −0.76 | −0.22 | −0.46 | 0.58 | −0.50 | −0.62 | — | — | — |
| (11) SOL | −0.48 | 0.35 | 0.23 | 0.42 | 0.20 | 0.13 | 0.22 | 0.35 | −0.52 | −0.43 | — | — |
| (12) WASO | −0.66 | 0.03 | 0.56∗ | 0.17 | −0.07 | −0.19 | −0.29 | 0.08 | −0.19 | −0.55 | 0.29 | — |
p < 0.05; p < 0.001. TL: training load; sIgA: secretory immunoglobulin A; TMD: total mood disturbance; TST: total sleep time; SE%: sleep efficiency; SOL: sleep onset latency; WASO: wake after sleep onset.
Figure 2Conceptual model of prior training volume to performance relationship illustrating moderated mediation effects of sleep efficiency x fatigue (B = unstandardized coefficients ± standard errors).
Figure 3Moderating effect of fatigue on the association between performance and sleep efficiency.